Skip to Main Content

National Coverage Determination (NCD) for Platelet-Derived Wound Healing Formula (270.3)

Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.

Benefit Category
Drugs and Biologicals

Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

Item/Service Description

A platelet-derived formula containing growth factors intended to treat nonhealing wounds (e.g., Procuren) is provided through hospital-based outpatient facilities as part of comprehensive wound- care programs designed to treat patients with chronic nonhealing wounds. It is usually applied at first in the presence of a physician, with the patient continuing applications at home.


Indications and Limitations of Coverage

There is a lack of sufficient published data to determine the safety and efficacy of the platelet-derived wound healing formula (based on a technology review by the Public Health Service). Therefore, it is not covered under Medicare because it is not considered reasonable and necessary within the meaning of §1862(a)(1) of the Act.


Transmittal Number

63

Revision History

12/1992 - Reflected noncoverage policy. Effective date 12/28/92. (TN 63)


Other Versions
39